Literature DB >> 1340993

[Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].

J Chesta1, G Generini, C Antezana, C Defilippi.   

Abstract

Patients with liver cirrhosis develop marked abnormalities in small bowel motility and high plasma glucagon levels. Disturbances in small intestinal motor activity could be related to hyperglucagonemia. To investigate the relationship between fasting plasma glucagon levels and changes in small bowel motility in patients with liver cirrhosis, eighteen cirrhotic patients and ten controls were studied. Plasma glucagon was measured by RIA. Mouth to cecum transit time was estimated by lactulose hydrogen breath test. Fasting small bowel motility was investigated by means of intraluminal manometry. Plasma glucagon levels were significantly higher in patients with cirrhosis (61 +/- 5 pmol/l) than in controls (32 +/- 3 pmol/l); p < 0.01. In patients with liver disease, plasma glucagon levels were not significantly correlated to mouth to cecum transit time (r: -0.32), duration of migrating motor complex (r: -0.24), nor to the frequency of multiple clustered contractions (r: -0.26). The degree of small bowel dysmotility is not related to plasma glucagon levels in patients with hepatic cirrhosis. These results do not support the hypothesis that hyperglucagonemia plays an important pathogenic role in the abnormalities of gut motility in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1340993

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis.

Authors:  N Veal; H Auduberteau; C Lemarie; F Oberti; P Calès
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease.

Authors:  A M Madrid; F Cumsille; C Defilippi
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.